{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:28:40Z","timestamp":1787725720943,"version":"build-2784847793"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"\n Introduction<\/jats:title>\n Long-acting injectable antipsychotics (LAIAs) may improve treatment continuity in schizophrenia, yet their acceptance in community-based care remains limited. This study examined factors associated with willingness to use LAIAs and dyadic perceptions and barriers among patients with schizophrenia and their primary caregivers in Yangpu District, Shanghai, where LAIA services and financial support were available.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This convergent mixed-methods study included a paired questionnaire survey of 425 community-managed patients who met LAIA treatment criteria but had not used LAIAs and their primary caregivers. Semi-structured interviews were conducted with 32 patient\u2013caregiver dyads until information saturation was reached. Quantitative and qualitative findings were integrated using a joint display.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Willingness to use LAIAs was low among patients and caregivers (17.4% and 17.6%), and awareness was limited in both groups (26.6% and 28.0%). Four dyadic willingness profiles were identified: concordant unwillingness, patient-only willingness, caregiver-only willingness, and concordant willingness. Higher patient willingness was associated with female sex, patient LAIA awareness, physician recommendation at the highest frequency, and caregiver willingness, whereas higher caregiver willingness was associated with caregiver LAIA awareness, being married, and patient willingness. Qualitative findings explained low acceptance through safety and injection concerns, treatment inertia, limited knowledge, reliance on physicians, family-based decision-making, and service accessibility barriers.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n These findings suggest that supporting informed LAIA acceptance may require patient\u2013caregiver-centered decision support, safety communication, and coordinated follow-up beyond service availability and cost support.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1931871","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:57:46Z","timestamp":1787723866000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Low willingness and patient\u2013caregiver concordance regarding long-acting injectable antipsychotics in schizophrenia cases: a convergent mixed-methods study"],"prefix":"10.3389","volume":"17","author":[{"given":"Huaiming","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Community Psychiatry, Mental Health Center Affiliated to Shanghai University of Medicine & Health Sciences","place":["Shanghai, China"]},{"name":"Department of Prevention and Treatment, Shanghai Yangpu Mental Health Center","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Public Health, National Health Commission (NHC) Key Laboratory of Health Technology Assessment, Key Laboratory of Public Health Safety, Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Community Psychiatry, Mental Health Center Affiliated to Shanghai University of Medicine & Health Sciences","place":["Shanghai, China"]},{"name":"Department of Prevention and Treatment, Shanghai Yangpu Mental Health Center","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengnan","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Community Psychiatry, Mental Health Center Affiliated to Shanghai University of Medicine & Health Sciences","place":["Shanghai, China"]},{"name":"Department of Prevention and Treatment, Shanghai Yangpu Mental Health Center","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Public Health, National Health Commission (NHC) Key Laboratory of Health Technology Assessment, Key Laboratory of Public Health Safety, Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"He","sequence":"additional","affiliation":[{"name":"School of Public Health, National Health Commission (NHC) Key Laboratory of Health Technology Assessment, Key Laboratory of Public Health Safety, Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Community Psychiatry, Mental Health Center Affiliated to Shanghai University of Medicine & Health Sciences","place":["Shanghai, China"]},{"name":"Department of Prevention and Treatment, Shanghai Yangpu Mental Health Center","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Public Health, National Health Commission (NHC) Key Laboratory of Health Technology Assessment, Key Laboratory of Public Health Safety, Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaowei","family":"Fu","sequence":"additional","affiliation":[{"name":"School of Public Health, National Health Commission (NHC) Key Laboratory of Health Technology Assessment, Key Laboratory of Public Health Safety, Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","unstructured":"Schizophrenia\n \n \n World Health Organization\n \n 2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s2215-0366(18)30511-x","article-title":"Prevalence of mental disorders in China: a cross-sectional epidemiological study","volume":"6","author":"Huang","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3961\/jpmph.24.201","article-title":"Potential increasing trend in schizophrenia relapse prevention in the past 40 years: a bibliometric analysis","volume":"57","author":"Syarif","year":"2024","journal-title":"J Prev Med Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s2215-0366(18)30090-7","article-title":"Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial","volume":"5","author":"Hui","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"B5","article-title":"Clinical guidelines for mental disorders (2020 edition)","year":"2020"},{"key":"B6","volume-title":"National Basic Public Health Service Specification","year":"2017"},{"key":"B7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41537-025-00623-z","article-title":"Economic well-being and its association with family caregiving experiences of households affected by schizophrenia in China","volume":"11","author":"Wang","year":"2025","journal-title":"Schizophrenia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41537-025-00637-7","article-title":"Long-term outcomes of Aripiprazole long-acting injectable: a 10-year mirror image study of patient acceptability and treatment effectiveness","volume":"11","author":"Barnett","year":"2025","journal-title":"Schizophrenia"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/20451253251403263","article-title":"Impact of treatment with long-acting injectable antipsychotics on hospitalization and relapse rates in schizophrenia spectrum disorders: a 3-year follow-up mirror-image study","volume":"16","author":"de Filippis","year":"2026","journal-title":"Ther Adv Psychopharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn113661-20240123-00037","article-title":"Chinese experts consensus on maintenance treatment of schizophrenia(2024)","volume":"57","year":"2024","journal-title":"Chin J Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.in18031ah1c","article-title":"Optimizing treatment choices to improve adherence and outcomes in schizophrenia","volume":"80","author":"Kane","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.951544","article-title":"Attitude and influencing factors of patients with schizophrenia toward long-acting injections: a community-based cross-sectional investigation in China","volume":"10","author":"Sun","year":"2022","journal-title":"Front Public Health"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.770276","article-title":"Attitudes and willingness to accept long-acting injections for patients with schizophrenia in Beijing: a cross-sectional investigation based on samples from the communities","volume":"9","author":"Zhu","year":"2021","journal-title":"Front Public Health"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5152\/alphapsychiatry.2024.241591","article-title":"The use and evaluation of long-acting injectable antipsychotic medications in community-dwelling patients with schizophrenia in Guangdong Province, China","volume":"25","author":"Wang","year":"2024","journal-title":"Alpha Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12991-020-00293-4","article-title":"The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: a clinical review","volume":"19","author":"Fiorillo","year":"2020","journal-title":"Ann Gen Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-025-00838-3","article-title":"The use of long-acting injectables for people with schizophrenia: consensus panel recommendations for overcoming barriers and implementing treatment","volume":"14","author":"Kane","year":"2025","journal-title":"Neurol Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1645328","article-title":"Experiences and perceptions of patients, caregivers, and healthcare professionals with long-acting injectable antipsychotics for the treatment of schizophrenia: qualitative results from the multinational ADVANCE study","volume":"16","author":"Franzenburg","year":"2025","journal-title":"Front Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s2215-0366(21)00437-5","article-title":"Family interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis","volume":"9","author":"Rodolico","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"B19","first-page":"21","volume-title":"Notice on Issuing the National Basic Public Health Service Standards","year":"2017"},{"key":"B20","volume-title":"Notice on Issuing the Shanghai Mental Health System Development Plan (2020\u20132030)","year":"2020"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21212","article-title":"The serious mental illness management system in China: concerns to be addressed","volume":"23","author":"Tang","year":"2024","journal-title":"World Psychiatry"},{"key":"B22","volume-title":"Clinical Guidelines for the Diagnosis and Treatment of Mental Disorders (2020 Edition)","year":"2020"},{"key":"B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2318-13-59","article-title":"How much do elders with chronic conditions know about their medications","volume":"13","author":"Chan","year":"2013","journal-title":"BMC Geriatr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.s251812","article-title":"Patients' preference for long-acting injectable versus oral antipsychotics in schizophrenia: results from the patient-reported medication preference questionnaire","volume":"14","author":"Blackwood","year":"2020","journal-title":"Patient Preference Adherence"},{"key":"B25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41537-023-00418-0","article-title":"Patient's disability and caregiver burden among Chinese family caregivers of individual living with schizophrenia: mediation effects of potentially harmful behavior, affiliate stigma, and social support","volume":"9","author":"Qiu","year":"2023","journal-title":"Schizophrenia"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2020.10.032","article-title":"Feeling responsible: family caregivers' attitudes and experiences of shared decision-making regarding people diagnosed with schizophrenia: a qualitative study","volume":"104","author":"Huang","year":"2021","journal-title":"Patient Educ Couns"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201800362","article-title":"Why and how family caregivers should participate in shared decision making in mental health","volume":"70","author":"Hamann","year":"2019","journal-title":"Psychiatr Serv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41537-023-00356-x","article-title":"Influencing factors of medication adherence in schizophrenic patients: a meta-analysis","volume":"9","author":"Guo","year":"2023","journal-title":"Schizophrenia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/1471-244x-13-261","article-title":"Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia","volume":"13","author":"Potkin","year":"2013","journal-title":"BMC Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-021-00861-6","article-title":"Controversies surrounding the use of long-acting injectable antipsychotic medications for the treatment of patients with schizophrenia","volume":"35","author":"Kane","year":"2021","journal-title":"CNS Drugs"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s326299","article-title":"Management of schizophrenia with long-acting injectable antipsychotic medications: an assessment of the educational needs of clinicians","volume":"18","author":"Citrome","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/00469580221148867","article-title":"The challenges of caring for an adult child with schizophrenia in the family: an analysis of the lived experiences of older parents","volume":"60","author":"Sharifi","year":"2023","journal-title":"Inquiry-the J Health Care Organ Provision Financing"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/1078390316685404","article-title":"Parents caring for adult children with serious mental illness","volume":"23","author":"Raymond","year":"2017","journal-title":"J Am Psychiatr Nurses Assoc"},{"key":"B34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12888-020-02633-w","article-title":"A cross-sectional study on spouse and parent differences in caregiving experiences of people living with schizophrenia in rural China","volume":"20","author":"Yu","year":"2020","journal-title":"BMC Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1931871\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:57:49Z","timestamp":1787723869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1931871\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":34,"alternative-id":["10.3389\/fpsyt.2026.1931871"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1931871","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1931871"}}